Irinotecan HCl

CAS

100286-90-6                 

SPECIFICATION

USP

REGULATORY STATUS

USDMF No.23522, USFDA  Approved,

CEP: R0-CEP 2020-025- Rev 00, 

Stability Studies In Zone IVB, WC available